News and Announcements
Quarterly Activities & Cashflow Report | Optiscan
- Published April 30, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights for the Quarter
- Met with the United States Food and Drug Administration seeking feedback for a 510(k) submission in Oral Cancer Surgery and/or Oral Cancer Screening.
- Progress in Oral Cancer Trials and Studies being led by Memorial Sloan Kettering Cancer Centre, Melbourne Dental School and Australian Centre for Oral Oncology Research and Education.
- Leading medical journal, Nature Biomedical Engineering, published study confirming potential of OptiScan technology.
- Revenue from Carl Zeiss Meditec of approximately $500k.
- Delivery of a FIVE2 (ViewnVivo) system to a university in Shanghai –OptiScan’s first China sale with
new distribution arrangements. - Receipt of $211k from financing of Research and Development Tax Credit.
To read the full quarterly report click here.
About Optiscan
OptiScan (ASX:OIL) is an Australian listed company and a pioneer in the development and application of endomicroscopic imaging technologies for medical markets. Our multi-patented confocal imaging technology can be used for both cancer screening and tumour margin detection in cancer surgery. Our device enables real-time, in vivo imaging at the cellular level in clinical applications, providing a “digital” biopsy. The benefits of this “digital” biopsy include monitoring of early stage disease, earlier identification of pre-cancer and the potential to reduce the time doctors, patients and operating theatres are required to wait for pathology results, the number of repeat surgeries and actual biopsies required.
Company Updates
Forget Startups: Why Magnetic Alliance is Betting on “Boring” Mid-Market Turnarounds
While Australia’s venture capital scene spent years chasing unprofitable tech startups and speculative high-growth plays, Mark Lim was quietly taking a radically different path. The Managing Partner of Magnetic Alliance Capital sees the nation’s richest investment opportunities hiding in plain sight: inside thousands of unglamorous, profitable, but operationally sluggish mid-market businesses. Speaking on Wholesale Investor’s […]
The asset class where the market has no vote
Litigation funding returns are decided in a courtroom, not a cycle. Knightsbridge’s Head of Capital is careful to call that a different risk rather than a lower one, and his answer to it is spread, not concentration. Most alternative assets still answer to something. Property answers to rates. Private credit answers to defaults. Even the […]
The listing fee vendors pay whether the house sells or not
Australia’s property portals collect more than $2 billion a year while national listings sit flat. An Australian-built AI platform is targeting the economics, not just the interface. An Australian vendor listing a home pays a vendor-paid advertising fee on top of agency commission. Rama Dwarapudi, Founder and Chief Executive Officer of RealSearch, puts a typical […]
Backed By Leading Investment Groups and Family Offices
